Markus Rimann

ZHAW Zurich University of Applied Sciences

Papers

1

Total Citations

28

H-Index

1

About

Markus Rimann is a pioneering researcher at the intersection of tissue engineering and drug development, whose work has significantly advanced the automation of three-dimensional (3D) cell culture systems. His primary research areas include 3D cell biology, biomaterials, and high-throughput screening technologies for pharmaceutical applications. Rimann’s major contribution lies in demonstrating how chemically defined hydrogels can be integrated into automated platforms to create reproducible 3D cell culture environments, addressing a critical bottleneck in drug development. His seminal 2013 paper, which has garnered 28 citations, highlights the limitations of traditional 2D monolayer assays and provides a robust framework for adopting 3D formats that better mimic in vivo cellular behavior. This work has paved the way for more physiologically relevant drug screening, potentially reducing late-stage drug failures. Rimann’s achievements underscore his role in bridging fundamental cell biology with industrial-scale automation, making him a key figure in the push toward more predictive preclinical models. His research continues to influence both academic labs and biotech companies striving to enhance the efficiency and accuracy of drug discovery pipelines.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Automation of 3D Cell Culture Using Chemically Defined Hydrogels
28 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: ZHAW Zurich University of Applied Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago